PIK3CD and cancer: The expression level of miR-218 in metastatic PCa tissues is much lower than that in primary PCa tissues (46), and miR-218 can inhibit the EMT, migration, and metastasis of cancer cells via GAB2/PI3K/AKT/GSK-3β (47).